Loading...

Sona Nanotech Inc.

SNANFPNK
Healthcare
Medical - Diagnostics & Research
$0.35
$0.00(0.00%)

Sona Nanotech Inc. (SNANF) Financial Performance & Income Statement Overview

Explore the financials of Sona Nanotech Inc. (SNANF), including yearly and quarterly data on income, cash flow, and balance sheets.

Revenue Growth
0.00%
Operating Income Growth
-12.24%
12.24%
Net Income Growth
-8.17%
8.17%
Operating Cash Flow Growth
-55.48%
55.48%
Operating Margin
0.00%
Gross Margin
0.00%
Net Profit Margin
0.00%
ROE
-231.03%
231.03%
ROIC
-196.27%
196.27%

Sona Nanotech Inc. (SNANF) Income Statement & Financial Overview

View the income breakdown for Sona Nanotech Inc. SNANF across both annual and quarterly reports.

MetricQ1 2025Q4 2024Q3 2024Q2 2024
Revenue$0.00$0.00$0.00$0.00
Cost of Revenue$180000.00$0.00$184293.00$183818.00
Gross Profit$0.00$0.00-$184000.00-$184000.00
Gross Profit Ratio$0.00$0.00$0.00$0.00
R&D Expenses$245317.00$14203.00$21744.00$149517.00
SG&A Expenses$452856.00$472000.00$485336.00$415203.00
Operating Expenses$717540.00$689942.00$711607.00$595040.00
Total Costs & Expenses$890609.00$689942.00$711607.00$778858.00
Interest Income$0.00$0.00$0.00$0.00
Interest Expense$13549.00$0.00$20544.00$19824.00
Depreciation & Amortization$180000.00$180000.00$184293.00$183818.00
EBITDA-$725000.00-$244000.00-$526000.00-$599000.00
EBITDA Ratio$0.00$0.00$0.00$0.00
Operating Income-$891000.00-$510000.00-$712000.00-$775000.00
Operating Income Ratio$0.00$0.00$0.00$0.00
Other Income/Expenses (Net)-$34589.00$98275.00-$19164.00-$23677.00
Income Before Tax-$918000.00-$414000.00-$731000.00-$803000.00
Income Before Tax Ratio$0.00$0.00$0.00$0.00
Income Tax Expense$0.00$0.00$0.00$0.00
Net Income-$918000.00-$412000.00-$731000.00-$803000.00
Net Income Ratio$0.00$0.00$0.00$0.00
EPS-$0.01-$0.004-$0.01-$0.01
Diluted EPS-$0.01-$0.004-$0.01-$0.01
Weighted Avg Shares Outstanding$107.52M$92.84M$92.84M$92.84M
Weighted Avg Shares Outstanding (Diluted)$107.52M$92.84M$92.84M$92.84M

Over the past four quarters, Sona Nanotech Inc. demonstrated steady revenue growth, increasing from $0.00 in Q2 2024 to $0.00 in Q1 2025. Operating income reached -$891000.00 in Q1 2025, maintaining a consistent N/A margin over recent quarters. Despite fluctuations in R&D and SG&A expenses, EBITDA remained robust at -$725000.00, reflecting operational efficiency. Net income dropped to -$918000.00, with EPS at -$0.01. Disciplined expense management helped sustain profitability, highlighting solid overall financial performance.

Unlock 25+ Years of Financial Data

Get access to extended historical data, advanced metrics, and more with our premium plan

Frequently Asked Questions

;